Self-mixed/split insulin regimen: A serious omission in the ADA/EASD position statement

Diabetes Care

Volumn 37, Issue 1, 2014, Pages 3-4

  Davidson, Mayer B ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE; SHORT ACTING INSULIN; ANTIDIABETIC AGENT;

BEDTIME DOSAGE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; DIABETES MELLITUS, TYPE 2; DOSE RESPONSE; DRUG ADMINISTRATION; EUROPE; INJECTION; MEDICAL SOCIETY; UNITED STATES;

DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EUROPE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS; INSULIN; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84892419402     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1665     Document Type: Note

References (13)

1. Inzucchi SE, Bergenstal RM, Buse JB, et al.Management of hyperglycemia in type 2 diabetes: A patient-centered approach:position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-1379
2. Raccah D, Bretzel RG, Owens D, Riddle M.When basal insulin therapy in type 2 diabetes mellitus is not enoughdwhat next Diabetes Metab Res Rev 2007;23:257-264
3. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203
4. Owens DR, Luzio SD, Sert-Langeron C,RiddleMC. Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: A 6-monthproof of-concept study. Diabetes Obes Metab 2011;13:1020-1027
5. Davidson MB, Raskin P, Tanenberg RJ, Vlajnic A, Hollander P. A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure. Endocr Pract 2011;17:395 403
6. Cusi K, Cunningham GR, Comstock JP. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM. Diabetes Care 1995;18:843-851
7. Monnier L, Colette C, Dunseath GJ, Owens DR. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 2007;30:263-269
8. Bonomo K, De Salve A, Fiora E, et al. Evaluation of a simple policy for pre-and post-prandial blood glucose selfmonitoring in people with type 2 diabetes not on insulin. Diabetes Res Clin Pract 2010; 87:246-251
9. Dailey G, Rosenstock J, Moses RG, Ways K.Insulin glulisine provides improved glycemic control in patients with type 2 diabetes.Diabetes Care 2004;27:2363-2368
10. Reeves ML, Seigler DE, Ryan EA, Skyler JS. Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion. Am J Med 1982;72:673-680
11. Umpierrez GE, Hor T, Smiley D, et al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. J Clin Endocrinol Metab 2009;94:564-569
12. Davidson MB, Blanco-Castellanos M, Duran P. Integrating nurse-directed diabetes management into a primary care setting.Am J Manag Care 2010;16:652-656
13. Ziel FH, Davidson MB, Harris MD, Rosenberg CS. The variability in the action of unmodified insulin is more dependent on changes in tissue insulin sensitivity than on insulin absorption. Diabet Med 1988;5:662-666